NPPB and atrial fibrillation: In our CCU cohort, the newly diagnosed AF group exhibited higher inflammatory burden and cardiac biomarker levels (NT‐proBNP, hs‐troponin) alongside higher in‐hospital mortality, aligning with this high‐risk phenotype and underscoring the need for early hemodynamic optimization and tailored rhythm/rate control strategies [20, 21].